QUANTINOVA
Live / Registered — Registered — Section 71 accepted (as of 19 Feb 2025)
What this means for you
Registered since 16 Sept 2014. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79144043
- Registration number
- 4603851
- Mark type
- Stylized text
- Filed
- 16 Oct 2013
- Published for opposition
- 01 Jul 2014
- Registered
- 16 Sept 2014
- Attorney of record
- Victoria Friedman
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for scientific and research use in the nature of sample preparation and for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for industrial and scientific purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; chemical reagents for conversion of RNA into cDNA for scientific research purposes; test kits comprising chemical preparations for industrial and scientific purposes, kits comprising reagents and solvents for scientific research use for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids, namely, kits comprising polymerase chain reaction (PCR) reagents for industrial and scientific research purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; kits comprising chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; kits comprising chemical reagents for conversion of RNA into cDNA for scientific research purposes
- Class 005 — Pharmaceuticals: [Diagnostic reagents for medical and veterinary medical purposes, medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes, kits comprising medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids; kits comprising polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; kits comprising reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes]
Owner
- Qiagen GmbH, Hilden, DE
- Qiagen GmbH, DE
- Qiagen GmbH, DE
Prosecution history
- 19 Oct 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 19 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 19 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 18 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Aug 2024 — TEAS SECTION 71 RECEIVED
- 16 Sept 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 31 Aug 2023 — INTERNATIONAL REGISTRATION RENEWED
- 03 Nov 2021 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 20 Sept 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 20 Sept 2021 — INVALIDATION PROCESSED
- 05 Sept 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 05 Jan 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 05 Jan 2021 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 07 Dec 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Aug 2020 — TEAS SECTION 71 & 15 RECEIVED